DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Market Report for Central Venous Catheters 2017 - MedCore" report to their offering.
The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional and antimicrobial acute CVCs. The acute CVC market is expected to grow only slightly over the forecast period, driven primarily by increases in the size and age of the European patient pool and the continued reliance on CVCs.
The acute CVC market is growing mainly due to the increasing use of antimicrobial CVCs for high-risk patients. These devices sell at a slight premium to conventional devices and the conversion to antimicrobial CVCs will lead to a growth in market value. The introduction of antithrombogenic CVCs has had a positive effect on the market.
Key Topics Covered:
Table Of Contents I
List Of Figures Xvii
List Of Charts Xxiii
European Market For Vascular Access Devices And Accessories Overview
Key Report Updates
3DT Holdings LLC
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
For more information about this report visit http://www.researchandmarkets.com/research/mvqr9l/european_market